PEPG
PepGen Inc.
Biotechnology · Healthcare · United States
2.36
close · 2026-10-30
value
15
cheaper than peers15
quality
34
stronger fundamentals34
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.37× | 69 |
| earnings yield, 3 years ago | -123.5% | 35 |
| cash flow yield, 3 years ago | -38.6% | 27 |
| earnings yield, 2 years ago | -139.8% | 26 |
| cash flow yield, 1 year ago | -50.8% | 25 |
| cash flow yield, latest year | -50.2% | 25 |
| cash flow yield, 2 years ago | -43.9% | 25 |
| earnings yield, latest year | -89.8% | 24 |
| earnings yield, 1 year ago | -120.8% | 18 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -75.5% | 42 |
| debt to equity | 13.5% | 36 |
3 of 4 measures available
Facts
| market cap | $163M |
| free cash flow | -$43.3M |
| employees | 57 |
| first trade | 2022-05-06 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.12 | -2.85 | -3.30 | -2.91 |
| free cash flow | -$81.9M | -$82.9M | -$71.6M | -$63.0M |
| net income | -$89.7M | -$90.0M | -$78.6M | -$69.1M |
| revenue | $0 | $0 | $0 | $0 |